Trial Profile
A 24-weeks pilot open-label prospective study of Dienogest in women with symptomatic rectovaginal endometriosis who had pain persistence.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Dienogest (Primary)
- Indications Endometriosis; Pain
- Focus Therapeutic Use
- 01 Sep 2015 New trial record